Pseudotropine

Pseudotropine

SCHEMBL38978

CN1C2CCC1CC(O)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 1.00
CYP2C9 P11712 1/20 1.00
CHRM3 P20309 6/20 0.42
CHRM2 P08172 5/20 0.42
CHRM1 P11229 5/20 0.42
TDP1 Q9NUW8 1/20 0.41
SLC6A2 P23975 2/20 0.38
SLC6A3 Q01959 2/20 0.38
OPRL1 P41146 1/20 0.37
HTR3E A5X5Y0 2/20 0.36
HTR3B O95264 2/20 0.36
HTR3A P46098 2/20 0.36
HTR3D Q70Z44 2/20 0.36
HTR3C Q8WXA8 2/20 0.36
CHRNA7 P36544 1/20 0.36
CHRM4 P08173 2/20 0.35
CHRM5 P08912 1/20 0.35
ADRA2A P08913 1/20 0.35
DRD2 P14416 1/20 0.35
ADRA2B P18089 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pseudotropine SCHEMBL6944859 1.00 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL21563309 1.00 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL100196 1.00 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL31078606 1.00 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL2442824 1.00 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL64824 1.00 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL745726 1.00 LMNA (1.00) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL228981 0.97 LMNA (0.94) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL7296801 0.97 LMNA (0.94) LMNACYP2C9CHRM3CHRM2CHRM1
Pseudotropine SCHEMBL7296808 0.97 LMNA (0.94) LMNACYP2C9CHRM3CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6333 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122075460-A Medical application of tolypic acid and derivative thereof in preparation of medicines for treating immune and inflammation related diseases 2026-05-26 CN claimed
US-12629360-B2 Ophthalmic composition Sydnexis, Inc. (US) 2026-05-19 US claimed
US-12540913-B2 Chemical sensor, reagent, and method for detecting benzoic acid and benzoic acid derivative KABUSHIKI KAISHA TOSHIBA (JP) 2026-02-03 US claimed
US-12480131-B2 Tropane alkaloid (TA) producing non-plant host cells, and methods of making and using the same THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2025-11-25 US claimed
EP-4642492-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
EP-4637708-A2 SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING HYOSCYAMINE Novaliq GmbH (DE) 2025-10-29 EP claimed
EP-4607278-A1 CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT Ycchem Co., Ltd. (KR) 2025-08-27 EP claimed
US-20250199405-A1 CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT YCCHEM CO., LTD. (KR) 2025-06-19 US claimed
US-20250186251-A1 OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF Sydnexis, Inc. 2025-06-12 US claimed
CN-119998727-A Chemically amplified positive resist composition for improving pattern profile and enhancing etch resistance YC化学制品株式会社 2025-05-13 CN claimed
EP-0112266-A2 Substituted tropyl and pseudotropyl benzoates and their use in migraine treatment MERRELL DOW FRANCE ET CIE (FR) 1984-06-27 EP claimed
EP-0045234-B1 DEALKYLATION PROCESS FOR TERTIARY AMINES BY THE USE OF ALPHA-CHLORINATED CHLOROFORMIATES SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1984-05-23 EP claimed
US-4405580-A Process for selective removal of H2 S from mixtures containing H22 with tertiary amino azabicyclic alcohols EXXON RESEARCH AND ENGINEERING CO. (US) 1983-09-20 US claimed
EP-0087207-A1 A process for removal of H2S from gaseous streams with amino compounds EXXON RESEARCH AND ENGINEERING COMPANY (US) 1983-08-31 EP claimed
US-4389393-A Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose FOREST LABORATORIES, INC. (US) 1983-06-21 US claimed
EP-0076088-A2 A photoconductive composition and a photoconductive element comprising the composition EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1983-04-06 EP claimed
EP-0067770-A2 Treatment of migraine with tropyl benzoate derivatives MERRELL DOW FRANCE ET CIE (FR) 1982-12-22 EP claimed
EP-0045234-A1 Dealkylation process for tertiary amines by the use of alpha-chlorinated chloroformiates SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1982-02-03 EP claimed
EP-0042365-A1 Salts of endo-8-methyl-8-syn-alkyl-8-azoniabicyclo-(3.2.1)-octane-3-alkylcarboxylates, process for their preparation and therapeutic compositions containing them VALEAS S.p.A. INDUSTRIA CHIMICA E FARMACEUTICA (IT) 1981-12-23 EP claimed
US-4001249-A CYCLOCOUPLING N-ACYLPYRROLE AND A,A*-HALOGENOKETONE, REDUCING AGENTS SANWA KAGAKU KENKYUSHO CO. LTD. (JA) 1977-01-04 US claimed